November 27, 2014 7:00 AM ET

Capital Markets

Company Overview of Columbine Ventures

Company Overview

Columbine Ventures is a private investment firm specializing in early stage venture funding. It typically invests in the biomedical field, including biotechnology, therapeutics, medical devices, bio-informatics and diagnostic technologies. The firm invests from $3 million up to $5 million per company. It prefers to invest in companies based in Israel. The firm prefers to have a representative on the board of the portfolio companies. Columbine Ventures was founded in 2000 and is based in Herzeliya Pituach, Israel.

Ackerstein Building

Entrance A

1st Floor

103 Medinat Hayehudim Street

Herzeliya Pituach,  46120

Israel

Founded in 2000

Phone:

972 9 956 5336

Fax:

972 9 950 5461

Key Executives for Columbine Ventures

Managing Director
Age: 52
Partner
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Fahn Kanne Consulting Ltd. Middle East/Africa
SePaYa Ltd Middle East/Africa
Psagot-Leumi & Co. Underwriting Middle East/Africa
Arba Finance Company Ltd. Middle East/Africa
Prisma Capital Markets Ltd. Middle East/Africa

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Columbine Ventures, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.